FDA Greenlights Genetic Test to Gauge Opioid Addiction Risk

The test will help healthcare providers to assess an individual's risk of developing opioid use disorder, offering a new approach to pain management.

Related Keywords

,Drug Administration ,Autogenomic Inc ,Autogenomics Inc ,Prevention Framework ,Clinical Considerations ,Devices Intended ,Treat Opioid Use Disorder ,Opioids ,Addiction ,Pain Management ,Genetics ,Spain ,Chronic Pain ,Acute Pain ,Genomics Genomic Medicine ,Overdose ,Rug Overdose ,Analgesia ,Analgesic ,Painkiller ,Isolation ,Quarantine ,Cheek ,Generics ,Generic Drug ,Eneric Medication ,